Lamivudine prophylaxis for prevention of chemotherapy-induced hepatitis B virus reactivation in hepatitis B virus carriers with malignancies
- 1 March 2004
- journal article
- research article
- Published by Wiley in Journal of Viral Hepatitis
- Vol. 11 (2), 141-147
- https://doi.org/10.1046/j.1365-2893.2003.00479.x
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Preemptive lamivudine therapy based on HBV DNA level in HBsAg-positive kidney allograft recipientsHepatology, 2002
- Preemptive use of lamivudine reduces hepatitis B exacerbation after allogeneic hematopoietic cell transplantationHepatology, 2002
- Lamivudine as Initial Treatment for Chronic Hepatitis B in the United StatesNew England Journal of Medicine, 1999
- A One-Year Trial of Lamivudine for Chronic Hepatitis BNew England Journal of Medicine, 1998
- Identification and characterization of mutations in hepatitis B virus resistant to lamivudineHepatology, 1998
- Emergence and takeover of YMDD motif mutant hepatitis B virus during long-term lamivudine therapy and re-takeover by wild type after cessation of therapyHepatology, 1998
- Hepatitis B Virus InfectionNew England Journal of Medicine, 1997
- Hepatitis B virus infection in allogeneic bone marrow transplantationBone Marrow Transplantation, 1997
- A Preliminary Trial of Lamivudine for Chronic Hepatitis B InfectionNew England Journal of Medicine, 1995
- Natural history and prognostic factors for chronic hepatitis type B.Gut, 1991